PhotoBioCure™ technology is based on polymeric materials that under the influence of UV radiation turn from a sticky liquid into a flexible solids. This feature allows forming a customized polymer implants, adjusted to tissue defects, in situ in vivo. Importantly, the composition is biodegradable in the in vivo environment and eventually replaced by natural tissue.

An important competitive feature is the ability to inject of the material through small incision (like in laparoscopic techniques). At the same time, the high viscosity of our biomaterial eliminates the need for sutures, which can be technically challenging and time-consuming, especially within a minimally invasive procedure.

Further, these biomaterials can be also bioactive as they biodegrade within the in vivo environment in a controllable process, thus facilitating tissue regeneration.


PhotoBioCure™ is a platform technology that has a number of surgical applications in the scope of tissue regeneration, especially in hernia treatment, cardiac procedures, orthopedics and several others.

So far, in vitro and in vivo (in rabbits) tests confirm the suitability of the material for the treatment of small hernia surgery. Hernia repair operations are one of the most common surgical procedures performed in the world, but unfortunately with a significant rate of complications and recurrence.

The technology is patented in US and Poland. Other Polish and EPO patents are pending.